Enrico Patrucco

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Author Correction: Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma.

Author Correction: Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma.

Journal: Nature medicine

Published: March 21, 2026

EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway.

EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway.

Journal: Cancer discovery

Published: March 18, 2025

SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRASG12D inhibitor in KRAS LUAD.

SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRASG12D inhibitor in KRAS LUAD.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 12, 2025

Oncogenic mutant KRAS inhibition through oxidation at cysteine 118.

Oncogenic mutant KRAS inhibition through oxidation at cysteine 118.

Journal: Molecular oncology

Published: June 09, 2024

Active thymus in adult with lung cancer: preliminary results from the Adult Thymic Project.

Active thymus in adult with lung cancer: preliminary results from the Adult Thymic Project.

Journal: Updates in surgery

Published: May 24, 2024

RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade.

RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade.

Journal: Nature communications

Published: November 21, 2023

cGMP-dependent kinase 2, Na+/H+ exchanger NHE3, and PDZ-adaptor NHERF2 co-assemble in apical membrane microdomains.

cGMP-dependent kinase 2, Na+/H+ exchanger NHE3, and PDZ-adaptor NHERF2 co-assemble in apical membrane microdomains.

Journal: Acta physiologica (Oxford, England)

Published: October 12, 2023

Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma.

Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma.

Journal: Science translational medicine

Published: June 28, 2023

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy.

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy.

Journal: Nature

Published: June 28, 2023

Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases.

Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases.

Journal: JTO clinical and research reports

Published: November 07, 2022

ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer.

ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer.

Journal: Nature cancer

Published: February 23, 2022

Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities of KRAS Mutations in Non-Small Cell Lung Cancer.

Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities of KRAS Mutations in Non-Small Cell Lung Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 28, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026